Halozyme Therapeutics Ownership | Who Owns Halozyme Therapeutics?
Halozyme Therapeutics Ownership Summary
Halozyme Therapeutics is owned by 96.27% institutional investors, 1.08% insiders, and 2.65% retail investors. Blackrock is the largest institutional shareholder, holding 13.88% of HALO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.17% of its assets in Halozyme Therapeutics shares.
HALO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Halozyme Therapeutics | 96.27% | 1.08% | 2.65% |
Sector | Healthcare Stocks | 46.98% | 7.90% | 45.12% |
Industry | Biotech Stocks | 44.85% | 7.67% | 47.48% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 17.62M | 13.88% | $922.58M |
Vanguard group | 12.88M | 10.15% | $674.47M |
State street | 5.81M | 4.58% | $304.43M |
Snyder capital management l p | 4.04M | 3.18% | $211.53M |
Artisan partners limited partnership | 3.72M | 2.93% | $194.64M |
Alliancebernstein | 3.55M | 2.80% | $185.83M |
Macquarie group | 3.08M | 2.42% | $161.14M |
Jpmorgan chase | 3.07M | 2.42% | $160.84M |
Geode capital management | 3.03M | 2.39% | $158.64M |
Td asset management | 2.37M | 1.86% | $123.88M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Snyder capital management l p | 4.04M | 4.74% | $211.53M |
Future fund | 36.30K | 4.74% | $1.89M |
Bernzott capital advisors | 187.25K | 4.52% | $9.80M |
Steamboat capital partners | 177.56K | 3.41% | $9.30M |
2xideas | 498.96K | 3.26% | $26.13M |
Koa wealth management | 73.57K | 3.26% | $3.85M |
Castellan group | 108.92K | 2.71% | $5.70M |
Harvey capital management | 186.04K | 2.56% | $9.74M |
Doheny asset management /ca | 123.56K | 1.89% | $3.31M |
Pier capital | 220.45K | 1.72% | $11.54M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Norges bank | 1.22M | 0.01% | 1.22M |
Frontier capital management | 846.23K | 0.44% | 602.19K |
Boston trust walden | 443.30K | 0.17% | 443.30K |
Millennium management | 423.19K | 0.01% | 291.12K |
Handelsbanken fonder ab | 1.11M | 0.25% | 284.30K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Thrivent financial for lutherans | 942.83K | 0.10% | -772.01K |
State street | 5.81M | 0.01% | -673.10K |
Blackrock | 17.62M | 0.02% | -621.61K |
Lazard asset management | 452.56K | 0.03% | -353.42K |
Balyasny asset management | 58.90K | 0.01% | -336.52K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 1.22M | 0.01% | 1.22M | $63.68M |
Boston trust walden | 443.30K | 0.17% | 443.30K | $23.21M |
Corebridge financial | 227.12K | 0.07% | 227.12K | $11.89M |
Lombard odier asset management (europe) | 200.00K | 0.50% | 200.00K | $10.47M |
Nicholas investment partners, lp | 152.87K | 0.83% | 152.87K | $8.00M |
Sold Out
Holder | Change |
---|---|
Newbridge financial services group | -10.00 |
Nelson, van denburg & campbell wealth management group | -26.00 |
Vitalstone financial | -67.00 |
Systm wealth solutions | -71.00 |
Fidelis capital partners | -1.28K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 458 | 9.05% | 122,203,811 | -0.27% | 96 | 1.03% | 237 | 8.22% | 158 | 11.27% |
Mar 31, 2024 | 420 | -0.24% | 122,538,335 | -1.36% | 96 | 1.09% | 219 | 2.82% | 142 | -0.70% |
Dec 31, 2023 | 421 | 5.25% | 124,225,834 | 2.20% | 94 | 1.11% | 213 | 18.33% | 143 | -2.05% |
Sep 30, 2023 | 400 | 4.71% | 121,555,932 | -1.37% | 92 | 1.05% | 180 | -0.55% | 146 | 9.77% |
Jun 30, 2023 | 382 | -2.55% | 123,244,378 | -0.82% | 93 | 1.10% | 181 | -4.23% | 133 | -13.64% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 4.03M | 3.17% | 3.36K |
iShares Core S&P Mid-Cap ETF | 3.99M | 3.13% | 2.16K |
iShares Russell 2000 ETF | 3.21M | 2.52% | -7.22K |
Vanguard Small Cap Index | 3.17M | 2.49% | -49.48K |
Aviva Investors GlConvtAbsRet I USD Acc | 2.74M | 2.16% | 2.74M |
SPDR® S&P Biotech ETF | 2.05M | 1.61% | 22.64K |
Vanguard Explorer Inv | 1.98M | 1.56% | 152.32K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.89M | 1.49% | -51.63K |
Vanguard Small Cap Growth Index Inv | 1.75M | 1.37% | -32.62K |
Delaware Small Cap Core I | 1.74M | 1.37% | -10.77K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 15, 2024 | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | $4.18K |
Oct 16, 2024 | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | $532.59K |
Oct 15, 2024 | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | Sell | $533.29K |
Oct 08, 2024 | Torley Helen | PRESIDENT AND CEO | Sell | $49.12K |
Oct 09, 2024 | Torley Helen | PRESIDENT AND CEO | Sell | $86.10K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 8 |
2024 Q3 | - | 25 |
2024 Q2 | - | 10 |
2024 Q1 | - | 6 |
2023 Q4 | - | 6 |
HALO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools